Literature DB >> 8488609

Use of tissue expanders in final reconstruction of infrapubic midline scar, mons pubis, and vulva after bladder exstrophy repair.

J F Eid1, P Rosenberg, K Rothaus, D Mininberg, L Hoffman, E D Vaughan.   

Abstract

Two patients following bladder exstrophy repair presented for final cosmetic reconstruction with the characteristic lower abdominal midline scar, bisected mons pubis, and laterally displaced labia majora. Tissue expanders were used to obtain additional skin and subcutaneous tissue. After adequate serial expansion, the expanders were removed, scar tissue excised, and primary approximation of healthy tissues performed. A tension-free closure and esthetically pleasing midline incision, mons pubis, and vulva were obtained.

Entities:  

Mesh:

Year:  1993        PMID: 8488609     DOI: 10.1016/0090-4295(93)90501-z

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  Female bladder exstrophy.

Authors:  S J Crankson; S Ahmed
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

Review 2.  What is a vulva?

Authors:  Matthew J Zdilla
Journal:  Anat Sci Int       Date:  2022-06-15       Impact factor: 1.693

3.  Social integration, sexual behavior and fertility in patients with bladder exstrophy--a long-term follow up.

Authors:  R Stein; K Hohenfellner; M Fisch; M Stöckle; R Beetz; R Hohenfellner
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

4.  Systematic Review of Tissue Expansion: Utilization in Non-breast Applications.

Authors:  Hannah C Langdell; Mahsa Taskindoust; Heather A Levites; Catalin Mateas; Amanda R Sergesketter; Samantha J Kaplan; Jeffrey R Marcus; Detlev Erdmann
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-21

5.  Aesthetic aspects of abdominal wall and external genital reconstructive surgery in bladder exstrophy-epispadias complex.

Authors:  Brian A VanderBrink; Jeffrey A Stock; Moneer K Hanna
Journal:  Curr Urol Rep       Date:  2006-03       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.